BRIGHTE Wk 240 Update
BRIGHTE Update: Wk 240 Results From Phase III Study of Fostemsavir + OBT in Heavily Treatment–Experienced People on Failing ART Regimens

Released: October 19, 2023

Activity

Progress
1
Course Completed